The company will receive an upfront payment of $10 million. It could also earn up to $75 million in development milestones, $100 million in sales milestones, and single-digit royalties on future ...

This article first appeared on GuruFocus. Oct 17 - Rani Therapeutics Holdings (NASDAQ:RANI) surged more than 150% on Friday morning after unveiling a partnership with Japan's Chugai Pharmaceutical Co.

Rani Therapeutics Holdings recently announced a collaboration and license agreement with Chugai Pharmaceutical for the joint development and commercialization of an oral product combining Rani’s ...

Rani Therapeutics has secured $69 million in new funding to move forward with the manufacturing and clinical testing of its “robotic pill”—a small, swallowable capsule that promises to shepherd more ...

ST. LOUIS — A female Asian elephant at the St. Louis Zoo died shortly after her herd became agitated from a small dog running loose, zoo officials said. Rani died Friday at age 27. The zoo announced ...

) has been revised to $10.71 / share. This is an increase of 20.00% from the prior estimate of $8.92 dated September 27, 2025. The price target is an average of many targets provided by analysts. The ...

The Polish musician is a mainstay of streaming playlists with names like “Calm Vibes.” But she bristles at the notion that her music is therapeutic. By Thomas Rogers Reporting from Warsaw and Berlin ...